CompoAtlas

MidNite PM

Natural health product licensed in Canada

Licence holder
Mylan Consumer Healthcare Inc.
NPN or DIN-HM
80038546
Status
Inactive licence
Licence date
8 January 2013
Revision date
Not provided
Form
Comprimé, à croquer
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Mélatonine1.5 mgNot calculated
Bromélaïne de tige

Source : Pineapple (Anannas comosus var. comosus (Bromeliaceae) - Stem

Potency : 24,000,000 FCC PU

20 mgNot calculated

Non-medicinal ingredients

Acide stéarique, xylitol, Stéarate de magnésium, Saveur de menthe poivrée naturelle, Melissa officinalis, silice, Matricaria recutita, Lavandula angustifolia

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1 Comprimé ; maximum: 2 CompriméNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

For relief of occasional minor knee pain and sleeplessness.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80038546

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line